Bharat Biotech to ramp up Covaxin production, make 200 mn doses a year

'Product availability of additional doses to commence from Q4, 2021 at Chiron Behring Vaccines Ltd, located in Ankleshwar, Gujarat,' Bharat Biotech says

Bharat Biotech --- which manufactures coronavirus vaccine "Covaxin" --- on Thursday announced plans to ramp up production of the vaccine at its subsidiary Chiron Behring Vaccines Ltd, located in Ankleshwar, Gujarat.

The company plans to produce 200 million doses of Covaxin per annum in Good manufacturing practice (GMP) facilities already operational for production of vaccines based on inactivated vero cell platform technology, under stringent levels of GMP and biosafety. 

"Product availability at Ankleshwar to commence from Q4 2021," Bharat Biotech said in a statement. 

The Company said it had already deployed multiple production lines at its Hyderabad and Bengaluru campuses,